Skip to main content
. 2017 Dec;9(12):5120–5130. doi: 10.21037/jtd.2017.11.54

Table 4. Risk factors relevant to severe exacerbations of COPD (emergency visits, hospitalization and ICU stay).

Clinical characteristics Emergency visits Hospitalization ICU stay
No (n=817) ≥1 (n=284) P No (n=586) ≥1 (n=515) P No (n=1,039) ≥1 (n=62) P
Age (year) 65.2±11.1 69.6±11.5 <0.001 63.4±11.2 69.6±10.5 <0.001 66.0±11.3 72.5±9.2 <0.001
Male 534 (65.4) 192 (67.6) 0.492 374 (63.8) 352 (68.3) 0.114 687 (66.1) 39 (62.9) 0.603
Height (cm) 165.1±8.4 165.4±7.9 0.631 164.9±8.3 165.6±8.1 0.145 165.2±8.3 165.9±8.0 0.517
Weight (kg) 62.1±12.1 60.2±12.2 0.023 62.5±12.1 60.5±12.1 0.007 61.7±12.2 60.0±12.1 0.255
BMI (kg/m2) 22.7±3.8 21.9±4.4 0.004 22.9±3.8 22.0±4.1 <0.001 22.5±4.0 21.8±4.3 0.150
Smoking status 0.209 <0.001 0.810
   Current- 193 (23.6) 57 (20.1) 167 (28.5) 83 (16.1) 238 (22.9) 12 (19.4)
   Ex- 366 (44.8) 144 (50.7) 233 (39.8) 277 (53.8) 480 (46.2) 30 (48.4)
   Never- 258 (31.6) 83 (29.2) 186 (31.7) 155 (30.1) 321 (30.9) 20 (32.3)
Smoking index (pack·year) 22.9±25.7 22.9±23.8 0.966 22.0±24.1 23.9±26.4 0.217 22.6±24.7 26.9±33.3 0.329
CB 641 (78.5) 249 (87.7) 0.001 434 (74.1) 456 (88.5) <0.001 832 (80.1) 59 (93.5) 0.009
mMRC dyspnea score < 0.001 <0.001 <0.001
   0 86 (10.5) 12 (4.2) 72 (12.3) 26 (5.0) 97 (9.3) 1 (1.6)
   1 319 (39.0) 63 (22.2) 239 (40.8) 143 (27.8) 371 (35.7) 11 (17.7)
   2 242 (29.6) 104 (36.6) 177 (30.2) 169 (32.8) 332 (32.0) 14 (22.6)
   3 117 (14.3) 62 (21.8) 73 (12.5) 106 (20.6) 161 (15.5) 18 (29.0)
   4 53 (6.5) 43 (15.1) 25 (4.3) 71 (13.8) 78 (7.5) 18 (29.0)
GOLD stage <0.001 <0.001 <0.001
   I 49 (6.0) 11 (3.9) 37 (6.3) 23 (4.5) 60 (5.8) 0 (0)
   II 262 (32.1) 64 (22.5) 220 (37.5) 106 (20.6) 316 (30.4) 10 (16.1)
   III 323 (39.5) 101 (35.6) 227 (38.7) 197 (38.3) 406 (39.1) 18 (29.0)
   IV 183 (22.4) 108 (38.0) 102 (17.4) 189 (36.7) 257 (24.7) 34 (54.8)

Data are presented as mean ± SD or number (%). COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; BMI, body mass index; CB, chronic bronchitis; mMRC, modified Medical Research Council; GOLD, Global Initiative for Chronic Obstructive Lung Disease.